SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
NVO Analysis & Videos »
NVO: Bull or Bear?
FDA, Clinical Trial Calendar Updates: Weight Loss, Diabetes, and More
NVO
|
|
|
+30.25%
in
225 days
<> The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA deadline dates. The entries are updated on a daily basis as new information becomes available with a total of 110 entries through 4/1/09. The FDA Calendar includes the following information: company name, ticker, decision d...
|
Upcoming FDA Advisory Panel Meetings
NVO
|
|
|
+16.10%
in
23 days
(closed on 04/01/09)
A trio of diabetes drug candidates are affected by a tougher stance at the FDA for this class of drugs, which is focused on cardiovascular risks such as heart attack and stroke. Two of the drugs will be reviewed at early April FDA advisory panel meeting while a third will likely require additional clinical trials. http://www.biomedreports.com/fda-calendar.html <> In December the FDA issued a new guidance document that recommended more stringent clinical trials for diabetes drugs to better assess heart attack and stroke risks. In a change that was effective immediately,...
|
Updated Clinical Trial and FDA Decision Calendars
NVO
|
|
|
-3.53%
in
3 days
(closed on 03/09/09)
<!-- Post Teaser Text --> <> Below is a summary of updates to the BioMedReports.com database of 233 entries included in the FDA and Clinical Trial Calendars . The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA deadline dates. <> The entries are updated on a daily basis as new information becomes available with a total of 101 entries through ...
|
Scandinavian Select Nordic Region Index
NVO
|
|
|
-18.65%
in
57 days
(closed on 03/06/09)
<> 
<>
The accompanying table [click to enlarge] includes statistics for all 82 companies in the ETF Innovators [ETFI] Scandinavian Select Nordic Region Index, which was last updated in mid-December.
This index tracks the performance of companies in the Nordic Region with market caps over $1B U.S. Dollars and would include the Top 35 Rated Companies as a new idea for a semi-active ETF with quarterly rebalancing as compared to the pending passive ETF for the Nordic Region filed by Global X whic...
|
A New Scandinavian Select Nordic Region Index
NVO
|
|
|
+1.72%
in
21 days
(closed on 01/08/09)
<> 
The accompanying table [click to enlarge] includes the Top 10 rated companies among a total of 82 which are included in the ETF Innovators [ETFI] Scandinavian Select Nordic Region Index. This index tracks the performance of companies in the Nordic Region with market caps over $1B U.S. Dollars, with the Top 35 Rated companies chosen as active components for a new semi-active ETF idea with quarterly rebalancing.
Since I last wrote about the index in mid-October , the number of Scandinavian companies with ma...
|
A New Index of Preventive Medicine Cos.
NVO
|
|
|
+6.71%
in
13 days
(closed on 12/17/08)
<> 
The accompanying table [click to enlarge] presents statistics and the top 15 rated companies in the ETF Innovators [ETFI] Preventive Medicine Index. The index includes U.S.-listed companies with market caps of $200M-$60B which are engaged in the following healthcare business segments: vaccine makers, diagnostics, lab services, and diabetes care.
The index has outpaced the overall market, Healthcare Sector SPDR (XLV), HealthShares Diagnostics (HHD), and iShares Nasdaq Biotech (IBB) over the past year, posting ...
|
Obama-Care Focused on Preventive Medicine
NVO
|
|
|
-1.06%
in
3 days
(closed on 11/08/08)
<> 
In addition to bullish outlooks for generic drugs and Health IT , President-Elect Obama's healthcare plan plans to focus on public health initiatives and mandated coverage of preventive services such as cancer screenings. The accompanying table presents statistics and the top five rated companies in the ETFI Preventive Medicine Index, including vaccine makers such as Emergent BioSolutions (EBS), diabetes care companies such as Novo Nordisk (NVO), diagnostic companies such as Sequenom (SQNM) and Myriad Geneti...
|
A Selective Investment in Scandinavia
NVO
|
|
|
+4.49%
in
16 days
(closed on 11/05/08)
<> 
As evidence of commercial interest in developing an ETF for the Nordic region, Global X Management has recently filed for such a product , based on the FTSE Nordic 30 Index. The Global X filing specifies that, "The underlying index tracks the performance of the 30 largest and most liquid companies in Sweden, Denmark, Norway, and Finland. The Adviser uses a passive or indexing approach to try to achieve the Fund’s investment objective."
In contrast, the ETFI Nordic Region PerformIdex is a semi-active ETF proposa...
|
Seven New ETF Opportunities
NVO
|
|
|
+4.02%
in
8 days
(closed on 10/20/08)
<> 
The accompanying tables present an overview of new global equity indexes and ETF proposals I have developed to provide investors with access to six industry groups and one geographic region that currently have no investment products on the market. Of these ideas, only the Nordic Region has a pending ETF filed with the SEC. The goal of these ideas is to provide investors with global equity index investment products which are more focused than broad-based ETFs such as iShares Dow Transports (IYT), Healthcare Sector SPDR (XLV), and Consume...
|
NordiCaps Region BULLISHares
NVO
|
|
|
-17.81%
in
36 days
(closed on 09/13/08)
  Click on the image above for a full-screen view of the 40 active component stocks in my NordiCaps Region Index. The statistics provided are current as of 5/22/08, reflecting the most recent update of the data for each company.
<> Moving beyond the single country focus of exchange-traded funds [ETFs] such as the iShares MSCI Sweden Index (EWD), I have developed a NordiCaps Region Stock Index which includes 120 companies based in Denmark, Finland, Iceland, Norway, and Sweden with market caps over $1 billion US Dollars. I have also developed a ratings formul...
|
Novo Nordisk (NVO) - the world's largest producer of insulin
NVO
|
|
|
-0.72%
in
10 days
(closed on 04/02/07)
Jim Cramer mentioned this stock yesterday and it jumped $1.43 because of the Cramer effect. I watch the Mad Money show, not for his stock picks but to educate myself on these companies he talks about...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
|
People Bullish on NVO
People Bearish on NVO
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
Be the first to start a discussion and earn 2 points.
More Resources
|
About NovoNordisk A/S
- Answers.com
